These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10389623)

  • 1. Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues.
    Yokose T; Doy M; Taniguchi T; Shimada T; Kakiki M; Horie T; Matsuzaki Y; Mukai K
    Virchows Arch; 1999 May; 434(5):401-11. PubMed ID: 10389623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies.
    Hamaoka N; Oda Y; Hase I; Asada A
    Br J Anaesth; 2001 Apr; 86(4):540-4. PubMed ID: 11573629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.
    Rifkind AB; Lee C; Chang TK; Waxman DJ
    Arch Biochem Biophys; 1995 Jul; 320(2):380-9. PubMed ID: 7625847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies specific and inhibitory to human cytochromes P450 2C8, 2C9, and 2C19.
    Krausz KW; Goldfarb I; Buters JT; Yang TJ; Gonzalez FJ; Gelboin HV
    Drug Metab Dispos; 2001 Nov; 29(11):1410-23. PubMed ID: 11602516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
    Minoletti C; Dijols S; Dansette PM; Mansuy D
    Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.
    Stearns RA; Chakravarty PK; Chen R; Chiu SH
    Drug Metab Dispos; 1995 Feb; 23(2):207-15. PubMed ID: 7736913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in cytochrome P450 enzymes by 1,1-dichloroethylene in rat liver and kidney.
    Hanioka N; Jinno H; Nishimura T; Ando M
    Arch Toxicol; 1997; 72(1):9-16. PubMed ID: 9458185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
    Wester MR; Lasker JM; Johnson EF; Raucy JL
    Drug Metab Dispos; 2000 Mar; 28(3):354-9. PubMed ID: 10681382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation.
    McSorley LC; Daly AK
    Biochem Pharmacol; 2000 Aug; 60(4):517-26. PubMed ID: 10874126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily.
    Ono S; Hatanaka T; Miyazawa S; Tsutsui M; Aoyama T; Gonzalez FJ; Satoh T
    Xenobiotica; 1996 Nov; 26(11):1155-66. PubMed ID: 8948091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted antipeptide antibodies to cytochrome P450 2C18 based on epitope mapping of an inhibitory monoclonal antibody to P450 2C51.
    Richardson TH; Griffin KJ; Jung F; Raucy JL; Johnson EF
    Arch Biochem Biophys; 1997 Feb; 338(2):157-64. PubMed ID: 9028867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamily.
    Ha-Duong NT; Dijols S; Marques-Soares C; Minoletti C; Dansette PM; Mansuy D
    J Med Chem; 2001 Oct; 44(22):3622-31. PubMed ID: 11606127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles.
    Roy P; Yu LJ; Crespi CL; Waxman DJ
    Drug Metab Dispos; 1999 Jun; 27(6):655-66. PubMed ID: 10348794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of human hepatitis anti-liver kidney microsomes (LKM2) autoantibodies on rat liver sections is predominantly due to reactivity with rat liver P-450 IIC11.
    Pons C; Dansette PM; Amar C; Jaouen M; Wolf CR; Gregeois J; Homberg JC; Mansuy D
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1328-34. PubMed ID: 1762080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies of differentiating specificities as probes of cytochrome P450h (2C11).
    Ryan DE; Thomas PE; Levin W; Maines SL; Bandiera S; Reik LM
    Arch Biochem Biophys; 1993 Mar; 301(2):282-93. PubMed ID: 7681658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
    Yamazaki H; Shimada T
    Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the expression on constitutive rat hepatic cytochrome P450 isozymes by 5-fluorouracil.
    Afsar A; Lee C; Riddick DS
    Can J Physiol Pharmacol; 1996 Feb; 74(2):150-6. PubMed ID: 8723027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
    Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
    J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A.
    von Moltke LL; Greenblatt DJ; Grassi JM; Granda BW; Venkatakrishnan K; Schmider J; Harmatz JS; Shader RI
    J Pharm Pharmacol; 1998 Sep; 50(9):997-1004. PubMed ID: 9811160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.